Bangalore: Rao Papineni, chief scientist and senior principal investigator in medical applications of nanotechnology at Carestream Health, Inc USA received patent on a path-breaking innovation in the field of cancer, reports The Hindu.
“This patent will potentially change the way radiation is administered. It will improve localisation and monitoring of tumour and will help in highly targeted delivery of drugs to kill cancer cells,” Rao said.
“In rough terms, nano-particles are like payload delivery vehicles that can enhance damage to cancer tissues and simultaneously reduce the toxicity of normal and healthy tissues during radiation treatment.”
“The title of the patent is ‘High Capacity Non-Viral Vectors.’ The non-viral vectors are nano-particles. The nano-particles will allow the drug particle to target the diseased site with pinpoint precision. The nano-particles will allow the drug to be released inside the diseased cell. They will enhance the function of the drug. Our nano-particles will carry the drug precisely with minimal collateral damage to healthy tissue,” Dr. Papineni said.